ReviewInternational journal of molecular sciences2022

Treatment of HFpEF beyond the SGLT2-Is: Does the Addition of GLP-1 RA Improve Cardiometabolic Risk and Outcomes in Diabetic Patients?

Martina Belli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.